Key result
Compound YZ-LY-0 potently inhibited the proliferation of Enterovirus 71 in vitro with an EC50 of 0.29 μM and low cytotoxicity, acting at an early stage of viral replication.
Why the study?
Does Compound YZ-LY-0 inhibit the proliferation of Enterovirus-71 in vitro?
Does Compound YZ-LY-0 inhibit the proliferation of Enterovirus-71 in vitro?
Effect estimate: EC50 0.29 μM
Compound YZ-LY-0 demonstrates potent in vitro inhibition of Enterovirus-71 replication at an early stage with high selectivity and low cytotoxicity, suggesting potential as a therapeutic option for hand-foot-and-mouth disease.
In recent years, hand-foot-and-mouth disease (HFMD), which is caused by Enteroviruses, has emerged as a serious illness. It affects mainly children under the age of five and results in high fatality rates. Enterovirus 71 (EV71) is the main causative agent of HFMD in China and currently there are no effective anti-viral drugs available to treat HFMD. In the present study, we screened compounds for inhibition of proliferation of EV71. Compound YZ-LY-0 stalled the life cycle of EV71. The inhibitor exhibited EC50 value of 0.29 μm against SK-EV006 strain of EV71. Notably, YZ-LY-0 had low cytotoxicity (CC50 > 100 μM) and a high selectivity index (over 300) in Vero and RD cells. YZ-LY-0 in combination with an EV71 RdRp inhibitor or an entry inhibitor showed an antagonistic effect at very low concentrations. However, at higher concentrations the inhibitors exhibited a synergistic effect in inhibiting viral replication. Preliminary results on investigation of the mechanism of inhibition indicate that YZ-LY-0 does not block the entry of the virus in the host cell, but instead inhibits an early stage of EV71 replication. Our studies provide a potential clinical therapeutic option against EV71 infections and suggest that a combined application of YZ-LY-0 with other inhibitors could be more effective in the treatment of HFMD.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2015) studied Enterovirus 71 (EV71) infection. Compound YZ-LY-0 vs. Control (0.5% DMSO) was evaluated on Inhibition of EV71 proliferation (EC50) (EC50 0.29 μM). Compound YZ-LY-0 potently inhibited the proliferation of Enterovirus 71 in vitro with an EC50 of 0.29 μM and low cytotoxicity, acting at an early stage of viral replication.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: